Apremilast Krka 10 mg film-coated tablets Apremilast Krka 20 mg film-coated tablets Apremilast Krka 30 mg film-coated tablets
- Licence status
- Active substances
- Apremilast, Apremilast, Apremilast
- Dosage Form
- Film-coated tablet
- Licence number
- PA1347/114/001
- Licence holder
- KRKA, d.d., Novo mesto
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- L04AA32 apremilast
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 14/06/2024